Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Andrzej Nycz
- Chris Masuo
- Luke Meyer
- Mike Zach
- William Carter
- Alex Walters
- Andrew F May
- Ben Garrison
- Brad Johnson
- Brian Sanders
- Bruce Moyer
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Gerald Tuskan
- Hsin Wang
- Ilenne Del Valle Kessra
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- Jerry Parks
- John Lindahl
- Joshua Vaughan
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Nedim Cinbiz
- Padhraic L Mulligan
- Paul Abraham
- Peter Wang
- Sandra Davern
- Tony Beard
- Vilmos Kertesz
- Xiaohan Yang
- Yang Liu

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).